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Peritoneal leiomyomatosis (PL) is a rare, benign, hormone-dependent lesion characterized by the presence of widespread peritoneal nodules of smooth muscle. Since it is usually associated with conditions in which hormonal levels are significantly raised, suppressive treatments such as castration (1) and antiestrogens (2) are considered the treatments of choice. However, reports of success with gonadotropin-releasing hormone (GnRH) analogues in the treatment of leiomyoma (3), a condition histologically and pathogenetically similar to PL, led us to believe that GnRH could also be beneficial in cases of PL. We report a case of a 42-year-old, non-pregnant patient suffering from PL who was treated with leuprolide acetate and in whom there was regression of the disease together with a marked A 42-year-old woman, gravida 3, para 3, last pregnancy in 1976, with no history of hormonal treatment, presented with stress incontinence in March 1989. She also requested tubal sterilization. On examination she was found to have a urethrocele. Abdominal ultrasound revealed subserosal myomatous nodules in the uterus. Pre-and postoperative levels of gonadotropins, estrogens and progesterone were normal.
Initially, the patient did not consent to hysterectomy or oophorectomy. Laparotomy revealed previously unsuspected widespread nodular tumors in the peritoneal surface involving the omentum, sigmoid colon, small intestine, uterine surface and left adnexal infundibulum which was anchored to the pelvis due to the presence of nodules. The nodules ranged in size from 1 m m to 5 cm. PL was diagnosed, the o m e n t u m and tubes were removed and multiple biopsies of the nodules were taken. Postoperative treatment consisted of daily subcutaneous injections with 500 ~g of leuprolide acetate for six months. Two months after completion of treatment, the patient consented to a second-look operation which showed a smooth intestinal serosa, all nodules having disappeared, a free and mobile left infundibulum and, after a thorough search, only four small miliary nodules in the uterine surface, the remainder of the o m e n t u m and the insertion of the appendix. The patient was discharged with no further treatment. No 'rebound' effect in the growth of peritoneal tumors is evident six months after discontinuation of therapy as demonstrated by ultrasound and repeat CAT scans.
Pathology
Nodules from the initial operation ranged from 1 m m to 5 cm in diameter, were well-delineated from surrounding structures and often pediculated. Histologically, there was a regular, fascicular smooth muscle proliferation without atypia or mitoses (Fig. 1 ). In contrast, the nodules from the second-look operation were m u c h smaller with a maximum diameter of only 5 m m their smooth muscle cells were obliterated by a concomitant fibrocollagenous c o m p o n e n t (Fig. 2) . In neither case was there any accompanying decidual metaplasia.
Electronmicroscopy showed typical smooth muscle cells, fibroblasts and myofibroblasts.
Discussion
The histogenesis of PL is considered to be a metaplastic smooth muscle change in the subperitoneal mesenchymal stem cells (2'4) which may show an abnormal response to high levels of circulating steroid hormones caused by pregnancy, oral contraceptives (2) or even functioning ovarian tumors (5). However, in very rare cases such as the one reported here, PL can occur when the hormonal status is apparently normal and it would seem that there exists a selective sensitivity of the peritoneal stem cells to promote smooth muscle growth.
PL associated with pregnancy may regress following delivery (2'6) although persistence of the disease is possible (2) . Since the growth of PL appears to be hormone dependent, the treatment advocated in the literature for persistent disease is castration (1) or antiestrogens (2) .
Uterine leiomyomata have been successfully treated with GnRH analogues which are used as an adjunct or even as an alternative to surgery. Follow-up studies using magnetic resonance imaging show a marked reduction in tumor size (3). The reversible hypoestrogenism induced by therapy has an effect similar to castration although rarely it may have the opposite effect and actually induce tumor growth (7) .
Both leiomyomata (a) and PL (9) showed increased estrogen and progesterone receptors, unlike leiomyosarcoma which has complete lack of receptors (1°). This phenomenon may explain why leiomyomata and PL respond to GnRH analogues whilst leiomyosarcoma does not.
The present case illustrates a striking positive response to GnRH analogue therapy with disappearance or marked reduction in size of nodules. An interesting histopathological finding was the increase of the fibroblastic component following treatment, indicative of regression. Since this case was not associated with initial abnormal hormonal levels, the regression was caused solely by the treatment and not due to removal of any hormonal source.
Once PL has been diagnosed histopathologically and leiomyosarcoma invading the peritoneum excluded, GnRH analogues may be useful in the treatment of persistent disease, as illustrated by the present case.
